Page 1

PRESS RELEASE Lasne 5 October 2026 18.00 Half - year results 2026 Net Asset Value of € 190 million ( + 47 % over 6 months ) Recurring net profit of € 2.1 million ( x3.5 over 12 months ) GROUP JJS Whitestone ⇒ As of 30 June 2026 , NAV is estimated at € 190 million , up € 61 million over the half - year ( + 47 % ) , of which € 54 million came from capital increases and nearly € 8 million from the increase in the estimated value of the portfolio ( + 5.5 % ) . ⇒ On a fully diluted per - share basis , NAV stands at € 18.4 , compared with € 18.1 at end - December 2025 ( + 1.7 % ) and € 17.1 at end - June 2025 ( + 7.6 % ) , which served as the reference for the capital raise . ⇒ Statutory recurring net profit amounted to € 2.1 million , compared to € 0.6 million a year earlier ( x3.5 ) , confirming the portfolio's capacity to contribute to the holding's results , driven in particular by the GFI dividend . ⇒ € 52 million was invested during the half - year , mostly in two new holdings , the Mäder group ( € 24.1 million ) and B Medical Systems ( € 16.7 million ) , demonstrating the holding company's ability to deploy its capital selectively and swiftly . → The holding company's net cash position increased by € 4.5 million to € 7.9 million , excluding available credit lines . KEY INDICATORS 30/06/26 31/12/25 Change NAV ( € m ) 189,9 129,0 + 47,2 % NAV per share , fully diluted ( € ) 18,4 18,1 + 1,7 % 17,1 ( 30/06/25 ) + 7,6 % Statutory recurring net profit ( € m ) 2,1 0,6 ( 30/06/25 ) + 255 % Investments during the half - year ( € m ) 51,8 Divestments during the half - year ( € m ) 0 Net cash - Wfin ( € m ) 7,9 3,4 + 132 % Number of shares , non - diluted 10.022.169 6.874.565 + 45,7 % Number of shares , fully diluted¹ 11.090.191 7.798.717 + 42,2 % Net Asset Value ( NAV ) up 47 % to € 190 million over 6 months NAV ( € m ) % change vs previous NAV NAV per share ( € ; fully diluted ) % change vs previous NAV 30/06/26 31/12/25 30/06/25 189,9 + 47,2 % 129,0 + 6,4 % 121,2 18,4 + 1,7 % 18,1 17,1 + 5,8 % 1. Taking into account all dilutive instruments issued and currently " in the money " . As the dilutive instruments are warrants , their exercise price will increase equity and cash if / when exercised . ISIN : BE0003840577 Ticker ROCK www.whitestone.eu